Amitriptyline Hydrochloride
Amitriptyline Hydrochloride is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
EASE (Efficacy of ATX01 Study in Erythromelalgia)
The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine
Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia
Clinical Trials (5)
EASE (Efficacy of ATX01 Study in Erythromelalgia)
The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine
Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5